Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Prothena Biosciences Ltd.

Home Clinical Trial Sponsors and OrganizationsProthena Biosciences Ltd.

Prothena Biosciences Ltd.

ACTIVE

Irelandwww.prothena.comSubsidiary

Part of Prothena Corp. Plc

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

8

0 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 2

3

37.5%

Phase 1

2

25.0%

Phase 3

2

25.0%

Trial Status Distribution

Completed

4

50.0%

Terminated

4

50.0%

Clinical Trials

Trials sponsored by this organization (8)

Phase 1 Study of PRX019 in Healthy Adult Volunteers

Nov 202450 participants

A Study to Evaluate the Efficacy and Safety of Birtamimab in Mayo Stage IV Patients With AL Amyloidosis

Aug 2021208 participants

Study in Subjects With Light Chain (AL) Amyloidosis

Jun 201780 participants

The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis

Mar 2016129 participants

Open-label Extension Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis

Feb 201634 participants

Quality of Life (QOL) Registry for Patients With AL Amyloidosis

Oct 2015343 participants

The VITAL Amyloidosis Study, a Global Phase 3, Efficacy and Safety Study of NEOD001 in Patients With AL Amyloidosis

Feb 2015260 participants

Phase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis

Apr 201369 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials8
Approvals
News

Back to Organizations